CIK 0001683553 · Non-accelerated filer<br>Smaller reporting company
SPRUCE BIOSCIENCES, INC.
Sign in to watch- Ticker
- SPRB
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 812154263
- Phone
- (415) 655-4168
- Business address
- 611 GATEWAY BOULEVARD, SUITE 740, SOUTH SAN FRANCISCO, CA, 94080
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 12 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-12-15 | Gharib Samir M. PRESIDENT AND CFO | Option exercise · Restricted Stock Units | −513 | 1,027 | ||
| 2025-12-11 | Ways Douglas Kirk Interim Chief Medical Officer | Option exercise | +1,250 | 1,250 | ||
| 2025-12-11 | Ways Douglas Kirk Interim Chief Medical Officer | Grant or award · Restricted Stock Units | +5,000 | 5,000 | ||
| 2025-12-11 | Ways Douglas Kirk Interim Chief Medical Officer | Option exercise · Restricted Stock Units | −1,250 | 3,750 | ||
| 2025-12-11 | Ways Douglas Kirk Interim Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +266 | 266 | ||
| 2025-12-11 | Ways Douglas Kirk Interim Chief Medical Officer | Returned to the company · Stock Option (Right to Buy) | −266 | 0 | ||
| 2025-12-11 | Ways Douglas Kirk Interim Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +400 | 400 | ||
| 2025-12-11 | Ways Douglas Kirk Interim Chief Medical Officer | Returned to the company · Stock Option (Right to Buy) | −400 | 0 | ||
| 2025-12-11 | Szwarcberg Javier B. CHIEF EXECUTIVE OFFICER | Grant or award · Employee Stock Option (right to buy) | +1,666 | 1,666 | ||
| 2025-12-11 | Szwarcberg Javier B. CHIEF EXECUTIVE OFFICER | Returned to the company · Employee Stock Option (right to buy) | −1,666 | 0 | ||
| 2025-12-11 | Walbert Keli Director | Grant or award · Stock Option (Right to Buy) | +3,400 | 3,400 | ||
| 2025-12-11 | Barretto-Ko Percival Director | Grant or award · Stock Option (Right to Buy) | +800 | 800 | ||
| 2025-12-11 | Barretto-Ko Percival Director | Returned to the company · Stock Option (Right to Buy) | −800 | 0 | ||
| 2025-12-11 | Szwarcberg Javier B. CHIEF EXECUTIVE OFFICER | Grant or award · Employee Stock Option (right to buy) | +10,000 | 10,000 | ||
| 2025-12-11 | Szwarcberg Javier B. CHIEF EXECUTIVE OFFICER | Returned to the company · Employee Stock Option (right to buy) | −10,000 | 0 | ||
| 2025-12-11 | SIMPSON CAMILLA V Director | Grant or award · Stock Option (Right to Buy) | +173 | 173 | ||
| 2025-12-11 | SIMPSON CAMILLA V Director | Returned to the company · Stock Option (Right to Buy) | −173 | 0 | ||
| 2025-12-11 | SIMPSON CAMILLA V Director | Grant or award · Stock Option (Right to Buy) | +309 | 309 | ||
| 2025-12-11 | SIMPSON CAMILLA V Director | Returned to the company · Stock Option (Right to Buy) | −309 | 0 | ||
| 2025-12-11 | SIMPSON CAMILLA V Director | Grant or award · Stock Option (Right to Buy) | +362 | 362 |
Page 2 of 12 · 231 trades